Treating facial atrophy in localized scleroderma by grafting stem cells from a patient’s own fat tissue appears to be a safe and effective alternative to existing methods, according to a small clinical study.

The findings were published in an article, “A pilot study on ex vivo expanded autologous adipose‐derived stem cells of improving fat retention in localized scleroderma patients,” in the journal Stem Cells Translational Medicine.

Read the full article at